Skip to content
10-Q

Quarterly Report

Arcus Biosciences, Inc. RCUS

0001724521-25-000101

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 106.43M sh
Shares Diluted Q2 2025 · Jun 30, 2025 106.5M sh
Shares Diluted Q2 2025 · Jun 30, 2025 102.3M sh
Shares Diluted Q2 2025 · Jun 30, 2024 91.1M sh
Shares Diluted Q2 2025 · Jun 30, 2024 88.6M sh
Capex Q2 2025 · Jun 30, 2025 $1M
Capex Q2 2025 · Jun 30, 2024 $4M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$265M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$96M
Long Term Debt Q2 2025 · Jun 30, 2025 $97M
Long Term Debt Q2 2025 · Dec 31, 2024 $48M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $248M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $150M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $156M
Stockholders Equity Q2 2025 · Jun 30, 2025 $549M
Stockholders Equity Q2 2025 · Mar 31, 2025 $531M
Stockholders Equity Q2 2025 · Dec 31, 2024 $485M
Stockholders Equity Q2 2025 · Jun 30, 2024 $635M
Stockholders Equity Q2 2025 · Mar 31, 2024 $707M
Stockholders Equity Q2 2025 · Dec 31, 2023 $462M
Current Liabilities Q2 2025 · Jun 30, 2025 $210M
Current Liabilities Q2 2025 · Dec 31, 2024 $226M
Current Assets Q2 2025 · Jun 30, 2025 $946M
Current Assets Q2 2025 · Dec 31, 2024 $1.02B
Total Assets Q2 2025 · Jun 30, 2025 $1.08B
Total Assets Q2 2025 · Dec 31, 2024 $1.15B
Eps Diluted Q2 2025 · Jun 30, 2025 $0.00
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.09
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.02
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.09
Eps Basic Q2 2025 · Jun 30, 2025 $0.00
Eps Basic Q2 2025 · Jun 30, 2025 −$1.09
Eps Basic Q2 2025 · Jun 30, 2024 −$1.02
Eps Basic Q2 2025 · Jun 30, 2024 −$1.09
Sga Expense Q2 2025 · Jun 30, 2025 $29M
Sga Expense Q2 2025 · Jun 30, 2025 $57M
Sga Expense Q2 2025 · Jun 30, 2024 $30M
Sga Expense Q2 2025 · Jun 30, 2024 $62M
Rd Expense Q2 2025 · Jun 30, 2025 $139M
Rd Expense Q2 2025 · Jun 30, 2025 $261M
Rd Expense Q2 2025 · Jun 30, 2024 $115M
Rd Expense Q2 2025 · Jun 30, 2024 $224M
Net Income Q2 2025 · Jun 30, 2025 $0
Net Income Q2 2025 · Jun 30, 2025 −$112M
Net Income Q2 2025 · Mar 31, 2025 −$112M
Net Income Q2 2025 · Jun 30, 2024 −$93M
Net Income Q2 2025 · Jun 30, 2024 −$97M
Net Income Q2 2025 · Mar 31, 2024 −$4M
Operating Income Q2 2025 · Jun 30, 2025 −$8M
Operating Income Q2 2025 · Jun 30, 2025 −$130M
Operating Income Q2 2025 · Jun 30, 2024 −$106M
Operating Income Q2 2025 · Jun 30, 2024 −$122M
Revenue Q2 2025 · Jun 30, 2025 $8M
Revenue Q2 2025 · Jun 30, 2025 $16M
Revenue restated Q2 2025 · Jun 30, 2024 $11M
Revenue restated Q2 2025 · Jun 30, 2024 $21M